| human | Q5 |
| P735 | given name | Michaela | Q776529 |
| Michaela | Q776529 | ||
| P106 | occupation | researcher | Q1650915 |
| Q59217385 | 134 Metabolic imaging of the aging heart: myocardial triglyceride content as independent predictor of diastolic function |
| Q59217658 | 135 Influence of short-term excessive dietary fat intake on myocardial triglyceride content and function |
| Q42153024 | A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes |
| Q48251771 | Absence of fatty acid transporter CD36 protects against Western-type diet-related cardiac dysfunction following pressure overload in mice |
| Q53073246 | Accelerated executive functions decline and gray matter structural changes in middle-aged type 1 diabetes patients with proliferative retinopathy |
| Q39435529 | Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes |
| Q43177498 | Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. |
| Q36990093 | Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial |
| Q44890971 | Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus |
| Q38072616 | Advances in pharmacologic therapies for type 2 diabetes |
| Q36533049 | Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease |
| Q57829475 | Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study |
| Q36892257 | Alterations in white matter volume and integrity in obesity and type 2 diabetes |
| Q36732144 | Altered Skeletal Muscle Fatty Acid Handling in Subjects with Impaired Glucose Tolerance as Compared to Impaired Fasting Glucose |
| Q48250050 | Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus |
| Q43264985 | Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging |
| Q37293974 | Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. |
| Q46291312 | Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients: response to Stettler et al. |
| Q42013167 | Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. |
| Q47736844 | Associations between life stress and subclinical cardiovascular disease are partly mediated by depressive and anxiety symptoms |
| Q34532934 | Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages |
| Q37456235 | Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients. |
| Q30361229 | Brain insulin signalling in the regulation of energy balance and peripheral metabolism. |
| Q42509392 | CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes |
| Q35672354 | Cardiometabolic risk variables in overweight and obese children: a worldwide comparison |
| Q34651892 | Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. |
| Q36302662 | Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes |
| Q44123900 | Carotid atherosclerosis in depression and anxiety: associations for age of depression onset. |
| Q37821167 | Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? |
| Q37331162 | Cerebral blood flow and glucose metabolism in appetite-related brain regions in type 1 diabetic patients after treatment with insulin detemir and NPH insulin: a randomized controlled crossover trial |
| Q42724909 | Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner |
| Q37031004 | Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes |
| Q100753948 | Cerebral effects of GLP-1 receptor blockade before and after Roux-en-Y Gastric Bypass in obese women: a proof-of-concept resting-state fMRI study |
| Q60677442 | Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes |
| Q33846616 | Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients |
| Q84342982 | Choosing a blood-glucose-lowering agent after metformin |
| Q33556613 | Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps |
| Q64355408 | Combining incretin-based drugs and RAAS inhibitors: more cons than pros? |
| Q28731529 | Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp |
| Q46811512 | Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus |
| Q50496660 | Continuous Glucose Monitoring in Patients with Type 1 Diabetes and Impaired Awareness of Hypoglycemia: Also Effective in Patients with Psychological Distress? |
| Q39376348 | Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. |
| Q46078962 | Correction: Common Variants in the Type 2 Diabetes KCNQ1 Gene Are Associated with Impairments in Insulin Secretion During Hyperglycaemic Glucose Clamp |
| Q52588934 | Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin |
| Q83266110 | Current studies of diabetic cardiomyopathy and the advancement of our knowledge: time to learn from history, guidelines, … and other disciplines? |
| Q49142919 | Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients |
| Q48907944 | Depression, anxiety, and arterial stiffness. |
| Q43739897 | Depressive and anxiety disorders and risk of subclinical atherosclerosis Findings from the Netherlands Study of Depression and Anxiety (NESDA). |
| Q35751626 | Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia |
| Q46429864 | Determinants of postprandial triglyceride and glucose responses after two consecutive fat-rich or carbohydrate-rich meals in normoglycemic women and in women with type 2 diabetes mellitus: the Hoorn Prandial Study |
| Q42737141 | Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle |
| Q58087772 | Diastolic Stiffness of the Failing Diabetic Heart |
| Q44522162 | Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus |
| Q46073101 | Differential effects of cross-sex hormonal treatment on plasma asymmetric dimethylarginine (ADMA) in healthy male-to-female and female-to-male transsexuals |
| Q34804363 | Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children |
| Q37716664 | Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy |
| Q60677500 | Differential regulation of cardiac GLUT4-mediated glucose and CD36-mediated fatty acid uptake by endosomal pH and actin filaments |
| Q42469955 | Differential regulation of cardiac glucose and fatty acid uptake by endosomal pH and actin filaments |
| Q49107139 | Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy |
| Q35123354 | Does Glucose Variability Influence the Relationship Between Mean Plasma Glucose and HbA1c Levels in Type 1 and Type 2 Diabetic Patients? |
| Q51330583 | Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial |
| Q43180130 | Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide |
| Q44051801 | Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma? |
| Q48714959 | Dynamic cerebral autoregulation in acute lacunar and middle cerebral artery territory ischemic stroke. |
| Q48270788 | Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels |
| Q39738896 | Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial |
| Q45089166 | Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: The EXAMI study |
| Q44738204 | Effect of cardiac hybrid ¹⁵O-water PET/CT imaging on downstream referral for invasive coronary angiography and revascularization rate |
| Q48329014 | Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial |
| Q48227892 | Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and its kidney clearance: post-hoc analyses of four clinical trials |
| Q43566584 | Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function |
| Q94667879 | Effects of a Hypercaloric and Hypocaloric Diet on Insulin-Induced Microvascular Recruitment, Glucose Uptake, and Lipolysis in Healthy Lean Men |
| Q33708984 | Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine |
| Q35179964 | Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes |
| Q33629852 | Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes |
| Q35150366 | Effects of insulin detemir and NPH insulin on body weight and appetite-regulating brain regions in human type 1 diabetes: a randomized controlled trial |
| Q73138058 | Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma |
| Q46568066 | Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects |
| Q81136659 | Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men |
| Q51365843 | Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well‐controlled type 2 diabetes patients* |
| Q40955003 | Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial |
| Q51318353 | Efficacy and tolerability of a high loading dose (25,000 IU weekly) vitamin D3 supplementation in obese children with vitamin D insufficiency/deficiency |
| Q62977647 | Elevated Endothelial Microparticles Following Consecutive Meals Are Associated With Vascular Endothelial Dysfunction in Type 2 Diabetes |
| Q48196644 | Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues |
| Q44205749 | Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus |
| Q47652208 | Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation |
| Q36240979 | Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes |
| Q40105467 | Endogenous GLP1 and GLP1 analogue alter CNS responses to palatable food consumption |
| Q82984599 | Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes |
| Q64271258 | Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050 |
| Q37097411 | Ethnic differences in cardiometabolic risk profile in an overweight/obese paediatric cohort in the Netherlands: a cross-sectional study |
| Q39220482 | Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males |
| Q34015968 | Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition |
| Q64355404 | Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial |
| Q42654585 | Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial |
| Q51472229 | Fasting and postprandial glycoxidative and lipoxidative stress are increased in women with type 2 diabetes |
| Q43224113 | Fasting cholesteryl ester transfer protein concentration is independently associated with the postprandial decrease in high-density lipoprotein cholesterol concentration after fat-rich meals: the Hoorn prandial study |
| Q59219234 | Fatty liver in uncomplicated type 2 DM is associated with impaired myocardial HEP metabolism, modulated by myocardial glucose uptake |
| Q48831712 | Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus |
| Q37360461 | Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study |
| Q46786763 | Functioning of oxidative phosphorylation in liver mitochondria of high-fat diet fed rats. |
| Q35613385 | GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight Men. |
| Q48632540 | GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans |
| Q36113842 | GLP-1-Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus: An Acute and 12-Week Randomized, Double-Blind, Placebo-Controlled Trial |
| Q47413989 | Gastric bypass may promote weight loss in overweight partners |
| Q58447993 | Gastric emptying, glucose metabolism and gut hormones: Evaluation of a common preoperative carbohydrate beverage |
| Q33556619 | Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function |
| Q35753332 | Genetically defined hyperlipidemia |
| Q34837085 | Genetically defined pancreatic beta cell failure |
| Q48071098 | Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. |
| Q42576497 | Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans. |
| Q50783813 | Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial |
| Q37921903 | Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? |
| Q39253117 | Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial. |
| Q45267810 | High prevalence of vitamin D insufficiency/deficiency in Dutch multi-ethnic obese children |
| Q35751610 | HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial |
| Q45981287 | Identifying the metabolic syndrome in obese children and adolescents: do age and definition matter? |
| Q29353657 | Impaired quality of life in treatment-seeking obese children of Dutch, Moroccan, Turkish and Surinamese descent |
| Q46538069 | Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: the Hoorn Study |
| Q51342852 | Increasing thyroid-stimulating hormone is associated with impaired glucose metabolism in euthyroid obese children and adolescents |
| Q28261998 | Incretin mimetics as a novel therapeutic option for hepatic steatosis |
| Q28568487 | Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats |
| Q48085912 | Intermittent fasting during Ramadan causes a transient increase in total, LDL, and HDL cholesterols and hs-CRP in ethnic obese adolescents. |
| Q45728583 | Islet-cell dysfunction induced by glucocorticoid treatment: potential role for altered sympathovagal balance? |
| Q46516320 | Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes |
| Q35708823 | Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial |
| Q45918480 | Limited value of routine microalbuminuria assessment in multi-ethnic obese children |
| Q50569576 | Liraglutide Reduces CNS Activation in Response to Visual Food Cues Only After Short-term Treatment in Patients With Type 2 Diabetes |
| Q42539644 | Liraglutide Treatment in a Patient With HIV and Uncontrolled Insulin-Treated Type 2 Diabetes |
| Q34237602 | Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism |
| Q47346661 | Lower birth weight is associated with alterations in dietary intake in adolescents independent of genetic factors: A twin study |
| Q51469323 | Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus |
| Q34457919 | Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes |
| Q28254549 | Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes |
| Q22241288 | Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). |
| Q35625640 | Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity |
| Q43643160 | Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects. Implications for a mechanism linking obesity and type 2 diabetes. |
| Q85002601 | Metabolic effects of high‐dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction |
| Q31130545 | Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers |
| Q36964906 | Microparticles and exosomes: impact on normal and complicated pregnancy |
| Q57393855 | Modular Kinetic Analysis of the Adenine Nucleotide Translocator-Mediated Effects of Palmitoyl-CoA on the Oxidative Phosphorylation in Isolated Rat Liver Mitochondria |
| Q42787147 | Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus. |
| Q33385879 | Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus |
| Q97544408 | NAFLD is related to Postprandial Triglyceride-enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction |
| Q46774939 | No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study |
| Q36839916 | Nonalcoholic fatty liver disease and cardiovascular disease risk |
| Q28287325 | Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial |
| Q24656644 | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial |
| Q43056507 | One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress |
| Q42516112 | Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes |
| Q35772433 | Overweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children |
| Q43132982 | Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk |
| Q40180663 | Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells |
| Q47915232 | Palmitic acid increases pro-oxidant adaptor protein p66Shc expression and affects vascularization factors in angiogenic mononuclear cells: Action of resveratrol. |
| Q40415039 | Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial. |
| Q50118366 | Pancreatic Steatosis Is Not Associated With Exocrine Pancreatic Function in Overweight Type 2 Diabetes Patients. |
| Q51466692 | Pancreatic fat content and beta-cell function in men with and without type 2 diabetes |
| Q37758064 | Pancreatic steatosis in humans: cause or marker of lipotoxicity? |
| Q34265956 | Parametric imaging of myocardial viability using ¹⁵O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR |
| Q38497043 | Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing |
| Q39742546 | Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1. |
| Q59219078 | Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin |
| Q33932844 | Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes |
| Q46059605 | Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus |
| Q51367341 | Postprandial changes in the phospholipid composition of circulating microparticles are not associated with coagulation activation |
| Q83186414 | Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome |
| Q38377453 | Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial |
| Q39521255 | Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells |
| Q80860454 | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients |
| Q46036417 | Proliferative retinopathy in type 1 diabetes is associated with cerebral microbleeds, which is part of generalized microangiopathy. |
| Q42818820 | Proline-rich Akt substrate of 40-kDa contains a nuclear export signal. |
| Q36426776 | Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: an 8-year follow-up of the Hoorn Study |
| Q30692074 | Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: comparison of MRI arterial spin labeling and [(15)O]H2O positron emission tomography (PET). |
| Q40598164 | Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial |
| Q57789501 | Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus |
| Q36047643 | Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables |
| Q36031668 | Retinal blood flow is increased in type 1 diabetes mellitus patients with advanced stages of retinopathy |
| Q36560244 | Right Ventricular Involvement in Diabetic Cardiomyopathy |
| Q59271368 | Right ventricular function and dimensions in type 2 diabetes mellitus |
| Q46287219 | Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease |
| Q46045171 | SGLT2 inhibitors for diabetes: turning symptoms into therapy. |
| Q38300001 | SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status. |
| Q41831179 | Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks |
| Q45091280 | Schizophrenia, syndrome X, and omega-3 fatty acids. |
| Q44068284 | Sensitivity to depression or anxiety and subclinical cardiovascular disease |
| Q82482666 | Sensor-augmented insulin-pump therapy in type 1 diabetes |
| Q36928027 | Serum 25-hydroxyvitamin D and parathyroid hormone in relation to plasma B-type natriuretic peptide: the Hoorn Study |
| Q80838545 | Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects |
| Q62977637 | Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent |
| Q42953407 | Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study |
| Q31150815 | Stroke volume measurements with first-pass dynamic positron emission tomography: comparison with cardiovascular magnetic resonance |
| Q35100504 | Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes |
| Q38872822 | Subgenual Cingulate Cortex Functional Connectivity in Relation to Depressive Symptoms and Cognitive Functioning in Type 1 Diabetes Mellitus Patients |
| Q87034029 | Systemic toll-like receptor and interleukin-18 pathway activation in patients with acute ST elevation myocardial infarction |
| Q37110602 | The CTRB1/2 locus affects diabetes susceptibility and treatment via the incretin pathway |
| Q36629552 | The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy |
| Q81310794 | The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function |
| Q45197389 | The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. |
| Q46434197 | The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin |
| Q46134952 | The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes |
| Q40381711 | The effects of GLP-1 based therapies on postprandial haemodynamics: Two randomised, placebo-controlled trials in overweight type 2 diabetes patients. |
| Q43450053 | The effects of long-term valsartan treatment on skeletal muscle fatty acid handling in humans with impaired glucose metabolism |
| Q51324172 | The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy |
| Q38174491 | The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? |
| Q46240290 | The heritability of HbA1c and fasting blood glucose in different measurement settings |
| Q42913245 | The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia |
| Q30356009 | The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD. |
| Q91120027 | The presence of cerebral white matter lesions and lower skin microvascular perfusion predicts lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls-A longitudinal study |
| Q44779341 | The relationship of lipoprotein lipase activity and LDL size is dependent on glucose metabolism in an elderly population: the Hoorn Study |
| Q35162317 | Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence |
| Q40581820 | Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial. |
| Q41744813 | Uncomplicated human type 2 diabetes is associated with meal-induced blood pressure lowering and cardiac output increase |
| Q43149437 | Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy? |
| Q28727779 | Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial |
| Q34718367 | Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial |
| Q84773087 | Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism |
| Q48690669 | Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathy |
| Q40282570 | Vesiculopustular dermatosis: an uncommon side-effect of liraglutide? |
Search more.